ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681639; 2) Community: the network communities that were significantly associated with the response to NSC 681639; 3) Molecule: the relationships between components within communities and NSC 681639; 4) MDR: the compounds that were significantly associated with the NSC 681639.

NSC Compound Enrichment Correlation
NSC 721386 5-Fluoro-2'-deoxyuridyl 2-(1,4-naphthoquinonyl)methyl N-methyl-N-(4-chlorobutyl) phosphoramidate 0.000323852502732648 0.5202614
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 0.000323852502732648 0.60531307
NSC 733883 6-(3-Chloropropyl)-5,6-dihydro-7-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 0.000323852502732648 0.55053038
NSC 681641 Camptothecin Derivative 0.000380874609232497 0.8774071
NSC 683556 Camptothecin Derivative 0.000380874609232497 0.85364989
NSC 606497 Camptothecin Derivative 0.000380874609232502 0.92773401
NSC 681633 Camptothecin Derivative 0.000380874609232502 0.94888667
NSC 634724 10,11-methylenedioxycamptothecin 0.000395532514722381 0.82948661
NSC 676315 Null 0.000395532514722381 0.24952226
NSC 683555 Camptothecin Derivative 0.000395532514722381 0.83610662
Total:56  Current:2    [First] [Prev] [Next] [Last]